Compare · INBS vs MDLN
INBS vs MDLN
Side-by-side comparison of Intelligent Bio Solutions Inc. (INBS) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INBS and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 10066.3x INBS ($4.8M).
- Over the past year, INBS is down 86.3% and MDLN is down 11.8% - MDLN leads by 74.5 points.
- MDLN has been more active in the news (7 items in the past 4 weeks vs 1 for INBS).
- MDLN has more recent analyst coverage (25 ratings vs 0 for INBS).
PerformanceINBS-74.75%MDLN-11.77%
2025-12-17+0.00%2026-10-16
- Company
- Intelligent Bio Solutions Inc.
- Medline Inc.
- Price
- $1.51+7.47%
- $35.95-1.74%
- Market cap
- $4.8M
- $48.08B
- 1M return
- -24.12%
- +11.97%
- 1Y return
- -86.27%
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2025
- News (4w)
- 1
- 7
- Recent ratings
- 0
- 25
Latest INBS
- SEC Form 8-K filed by Intelligent Bio Solutions Inc.
- SEC Form EFFECT filed by Intelligent Bio Solutions Inc.
- SEC Form 424B3 filed by Intelligent Bio Solutions Inc.
- SEC Form S-3 filed by Intelligent Bio Solutions Inc.
- SEC Form D filed by Intelligent Bio Solutions Inc.
- Intelligent Bio Solutions Inc. filed SEC Form 8-K: Other Events
- Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
- Intelligent Bio Solutions Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
- Intelligent Bio Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M